graphics getting more and more important -> also within smartphones ?
•Nvidia reported strong Q2 earnings, with revenue and earnings growing in the double-digits.
•AMD's GPU issues have not affected Nvidia, with its GTX gaming GPUs growing by 10%.
•Growth opportunities including a growing PC market, the ...
HPQ did not look attractive for many years but it seems it's back on track. Fundamentally and technically.
For cautious investors await 38+ breakout - but if you have a look at the daily chart we see a "buy the dips" opportunity.
tested major as well as minor support and JCI is forming a rebound pattern with a broader doji and bullish reversal candles. Minor resistance @ 46.64 which has to be taken in order to at least get back to 200 mvg and then 51.00 levels.
in at 82 catching early move, still must have
Since December 2013 Sovaldi is available in the US and
since January 2014 in some European countries while
approvals in various significant markets are still pending.
Based on its medical importance, I expect more
launches in due time. Medicare (US national ...
Although figures not that good as expected still very good story behind the company and holding breakout position after earnings miss. (CELG believes Otezla has achieved a market share lead for psoriatic arthritis shortly after its launch in April). Good fancy LT Buy and Hold. Downside limited.